SENOLYTICS – A DISCOVERY THAT COULD TRANSFORM THE COURSE OF AGING AND CHRONIC DISEASES
Authors:
- Kamil KaniaKKKamil Kania
- Marcel BobińskiMBMarcel Bobiński
- Zuzanna WieczorekZWZuzanna Wieczorek
- Wiktoria SkowronWSWiktoria Skowron
- Justyna BartolJBJustyna Bartol
- Aleksandra SosińskaASAleksandra Sosińska
- Justyna RajczykJRJustyna Rajczyk
- Monika Wiczuk–WiczewskaMWMonika Wiczuk–Wiczewska
- Adam SzymczakASAdam Szymczak
- Tomasz LepichTLTomasz Lepich
Open Access
- 6 January 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
Abstract
Senescent cells play a pivotal role in the progression of age-related diseases by promoting chronic inflammation and disrupting tissue function through the secretion of senescence-associated secretory phenotype (SASP) factors. Senolytics, a novel class of therapeutic agents, enable the selective elimination of these cells or the attenuation of their deleterious effects, offering a potential avenue to enhance healthspan. Preclinical studies and early clinical trials indicate that senolytics can improve cardiovascular function, metabolism, and physical performance, while demonstrating an acceptable safety profile. This review presents the mechanisms of action of senolytics, the current state of research, and their potential applications in metabolic, neurodegenerative, and cardiovascular diseases.Keywords
This publication has 57 references indexed in Scilit:
- A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer’s diseaseEBioMedicine, 2025
- Senescent cell depletion alleviates obesity-related metabolic and cardiac disordersMolecular Metabolism, 2024
- Current senolytics: Mode of action, efficacy and limitations, and their futureMechanisms of Ageing and Development, 2023
- Rationale and design of STAMINA: Senolytics to alleviate mobility issues and neurological impairments in aging, a geroscience feasibility studyTranslational Medicine of Aging, 2023
- Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in micePharmacological Research, 2022
- Senescence and senolytics in cardiovascular disease: Promise and potential pitfallsMechanisms of Ageing and Development, 2021
- Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot studyEBioMedicine, 2019
- SnapShot: Cellular Senescence PathwaysCell, 2017
- TRF2-Mediated Control of Telomere DNA Topology as a Mechanism for Chromosome-End ProtectionMolecular Cell, 2016
- Irreparable telomeric DNA damage and persistent DDR signalling as a shared causative mechanism of cellular senescence and ageingCurrent Opinion in Genetics & Development, 2014